SOLENO THERAPEUTICS INC - COM NEW (SLNO)

CUSIP: 834203200

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM NEW
Total 13F shares
27,947,522
Share change
-533,352
Total reported value
$11,456,477
Put/Call ratio
40%
Price per share
$0.41
Number of holders
32
Value change
-$308,174
Number of buys
10
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 834203200?
CUSIP 834203200 identifies SLNO - SOLENO THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SOLENO THERAPEUTICS INC - COM NEW (SLNO) as of Q4 2021

As of 31 Dec 2021, SOLENO THERAPEUTICS INC - COM NEW (SLNO) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,947,522 shares. The largest 10 holders included Abingworth LLP, Nantahala Capital Management, LLC, ORACLE INVESTMENT MANAGEMENT INC, VANGUARD GROUP INC, Granite Point Capital Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP, OPPENHEIMER & CO INC, and STATE STREET CORP. This page lists 32 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.